Dupilumab reduces exacerbations and improves lung function in uncontrolled, moderate-to-severe asthma patients across prior historical exacerbation subgroups in the phase 3 LIBERTY ASTHMA QUEST study

被引：0
|
作者：
Ford, L. [1 ]
Corren, J. [2 ]
Kuna, P. [3 ]
Dong, Q. [4 ]
Staudinger, H. [5 ]
Maroni, J. [6 ]
Rowe, P. [5 ]
Amin, N. [6 ]
Pirozzi, G. [5 ]
Ruddy, M. [6 ]
Akinlade, B. [6 ]
Graham, N. M. H. [6 ]
Teper, A. [5 ]
机构：
[1] Ctr Asthma & Allergy, Bellevue, WA USA
[2] Ronald Reagan UCLA Med Ctr, Santa Monica, CA USA
[3] Med Univ Lodz, Lodz, Poland
[4] Sanofi Genzyme, Cambridge, England
[5] Sanofi, Bridgewater, MA USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
来源：
ALLERGY | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0854
引用
收藏
页码：464 / 465
页数：2
相关论文
共 50 条
  • [21] DUPILUMAB IMPROVES ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA, REGARDLESS OF EXACERBATION HISTORY
    Corren, J.
    Castro, M.
    Maspero, J.
    Cosio, B.
    Kuna, P.
    Chen, Z.
    Staudinger, H.
    Chao, J.
    Nikhil, A.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    Khan, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S42 - S43
  • [22] A Randomized, Controlled Phase 3 Study, LIBERTY ASTHMA QUEST, Evaluating the Efficacy and Safety of Dupilumab in Uncontrolled Moderate-to-Severe Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J. F.
    Wenzel, S. E.
    Rabe, K. F.
    Busse, W. W.
    Ford, L. B.
    Sher, L.
    FitzGerald, J.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [23] Dupilumab Efficacy in LIBERTY ASTHMA QUEST Patients With Uncontrolled, Moderate-to-Severe Asthma By Allergen Sensitization Status
    Corren, Jonathan
    Jackson, David
    Casale, Thomas
    Borish, Larry
    Rabe, Klaus
    Busse, William
    Maspero, Jorge
    Jackson, Daniel
    Daizadeh, Nadia
    Ortiz, Benjamin
    Jacob-Nara, Juby
    Khodzhayev, Angela
    Rowe, Paul
    Djandji, Michel
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB15 - AB15
  • [24] DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN UNCONTROLLED PERSISTENT ASTHMA PATIENTS ACROSS BASELINE EXACERBATIONS
    Bernstein, J.
    Ford, L.
    Jayawardena, S.
    Maroni, J.
    Rowe, P.
    Amin, N.
    Pirozzi, G.
    Graham, N.
    Teper, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S50 - S50
  • [25] Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST
    Wenzel, S. E.
    Pavord, I.
    Zhang, B.
    Maroni, J.
    Rowe, P.
    Hamilton, J. D.
    Swanson, B. N.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [26] Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST
    Corren, J.
    Jackson, D. J.
    Casale, T. B.
    Daizadeh, N.
    Djandji, M.
    O'Riordan, T.
    Ortiz, B.
    Rowe, P.
    Deniz, Y.
    ALLERGY, 2020, 75 : 39 - 40
  • [27] Dupilumab improves health related quality of life in uncontrolled, moderate-to-severe asthma patients with comorbid allergic rhinitis from the phase 3 LIBERTY ASTHMA QUEST study
    Maspero, J.
    Busse, W. W.
    Katelaris, C. H.
    Yanez, A.
    Guillonneau, S.
    Chen, Z.
    Staudinger, H.
    Chao, J.
    Amin, N.
    Pirozzi, G.
    Ruddy, M.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    Khan, A.
    ALLERGY, 2018, 73 : 30 - 31
  • [28] Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma
    Castro, M.
    Rabe, K. F.
    Kraft, M.
    Corren, J.
    Pavord, I. D.
    Katelaris, C.
    Tohda, Y.
    Rice, M. S.
    Lu, Y.
    Rowe, P.
    Staudinger, H. W.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [29] Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study
    Guilbert, Theresa W.
    Tolcachier, Alberto
    Fiocchi, Alessandro G.
    Katelaris, Constance H.
    Phipatanakul, Wanda
    Begin, Philippe
    de Mir, Ines
    Altincatal, Arman
    Gall, Rebecca
    Ledanois, Olivier
    Radwan, Amr
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 143 - 159
  • [30] Effect of Dupilumab in Korean Patients With Uncontrolled Moderate-to-Severe Asthma: A LIBERTY ASTHMA QUEST Sub-analysis
    Rhee, Chin Kook
    Park, Jung-Won
    Park, Heung-Woo
    Cho, You Sook
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2022, 14 (02) : 182 - 195
12345